H, K., A, S., M, K., T, N., Y, K., H, S., & S, J. (2025). Biochemical and Plasma Lipid Responses to Pemafibrate in Patients With Primary Biliary Cholangitis and Dyslipidemia: A Four-Year Analysis. Cureus, 17(4), e83176. https://doi.org/10.7759/cureus.83176
Chicago Style (17th ed.) CitationH, Kobayashi, Sugiura A, Koyama-Otagiri M, Nimura T, Kurasawa Y, Shirakawa H, and Joshita S. "Biochemical and Plasma Lipid Responses to Pemafibrate in Patients With Primary Biliary Cholangitis and Dyslipidemia: A Four-Year Analysis." Cureus 17, no. 4 (2025): e83176. https://doi.org/10.7759/cureus.83176.
MLA (9th ed.) CitationH, Kobayashi, et al. "Biochemical and Plasma Lipid Responses to Pemafibrate in Patients With Primary Biliary Cholangitis and Dyslipidemia: A Four-Year Analysis." Cureus, vol. 17, no. 4, 2025, p. e83176, https://doi.org/10.7759/cureus.83176.